In this episode, Prof. Kristina Kusche-Vihrog, Director of the Lübeck Institute of Physiology, Germany, speaks about her fascinating work investigating the nanomechanical properties of cells, their role in physiological mechanisms and implications for medical conditions such as cardiovascular disease and hypertension.
She discusses the importance of endothelial cell stiffness in health, the role of the glycocalyx, and the impact of inflammatory processes on endothelial dysfunction. This episode explores bench-to-bedside AFM applications and potential future advancements in clinical diagnostics.
TO LEARN MORE:
Atomic Force Microscopy (AFM) is an imaging technique widely used in industry, materials, and life sciences. AFM technology advances have made it a powerful technique to study living cells in (near-)physiological conditions, called BioAFM.
In episode 1 of our AFM podcast “Conversations on AFM”, we learned more about the origins and impact of AFM from Prof Dr Mervyn Miles. We then moved on to learn about “Applications of BioAFM in the Life Sciences” in the podcast episode 2 with Dr. Andre Körnig .
Here, we explore how AFM is transforming biomedical research. For this, we have interviewed Prof Kristina Kusche-Vihrog, the Director of the Lübeck Institute of Physiology. Her research focuses on the influence of inflammatory processes on endothelial dysfunction as a precursor to the development of cardiovascular diseases and hypertension.
Endothelial Cells (ECs), which line our blood vessels, are central to maintaining blood flow and actively respond to physical and chemical changes. One key player in this is the actin cortex — a network of actin filaments just beneath the cell membrane — which plays a crucial role in determining cell stiffness. Another key feature of ECs is the glycocalyx, a thin mesh-like layer on the cell surface composed of sugars and proteins. The glycocalyx layer protects ECs from direct blood flow shear stress and plays a vital role in cell signalling, inflammation response, and vascular integrity. With the help of AFM, scientists can probe, measure and describe the glycocalyx and the underlying structures [1]
Dynamic morphological changes in living HUVEC cell, imaged at 37°C in full growth medium. Consecutive phase channel images show dynamic cellular events such as cytoskeleton reorganization (circle). Scan size: 7.17x7.17 µm. Sample courtesy of Prof. Dr. Stefan Zahler, LMU München, Germany.
When thinking about cellular stiffness, we need to distinguish between physiology and pathophysiology. In a physiologically healthy state, ECs respond to and regulate blood pressure by releasing the vasodilator nitric oxide (NO). Using AFM and cellular stiffness measurements, it was found that softer ECs tend to release more NO. On the other hand, cells that are older or affected by certain diseases are stiffer and thus can no longer effectively release NO for blood pressure regulation [2]. Research suggests that this process of stiffening does not just happen in healthy ageing but is also found in autoimmune diseases and chronic inflammation, linking cardiovascular and immune system health [3].
Prof. Kusche-Vihrog shares that when studying chronic kidney disease, using Primary Human Umbilical Vein Endothelial Cells (HUVECs) and incubating them with patient sera, ECs were found to have a damaged glycocalyx and were stiffened [4]. The research group also found that EC stiffness, on the single-cell level, could be extrapolated to larger parts of the arterial system. Thus, their data suggest that cellular stiffness is a predictor of the systemic immune and vascular system status.
Ideally, these findings could be taken further using patient sera with conditions like hypertension or autoimmune diseases to stratify patients based on their unique cellular mechanics, potentially leading to more personalised treatments. Patient stratification in this way could provide a foundation for precision medicine, where treatments are tailored to the patient’s specific vascular profile and immune response.
Altogether, AFM could be used in predictive diagnostics, potentially identifying vascular health issues and inflammation risks.
Prof. Kusche-Vihrog shared with us that auto-antibody-mediated effects in a COVID-19 infection can lead to glycocalyx shedding and cell stiffening, effects which were correlated to levels of proinflammatory cytokines [5]. Together with collaborators, she is currently working to understand whether similar auto-antibody-mediated effects are observed in ECs for the autoimmune disease systemic sclerosis [6]. This adds to other AFM applications in systemic sclerosis, where it was found that fibroblasts are softer but with an unaltered surface topography in patients [7].
Although AFM excels at reliably quantifying cell mechanics, Prof. Kusche-Vihrog says that a key challenge is the expertise needed to work with living cells while maintaining their optimal condition throughout experiments. She also hopes that AFM measurements will be standardised to a point where AFM can be used as a diagnostic tool in clinics.
You can also download our ressource collection to learn more about AFM technologies and their application.
You can find detailed applications and technical notes, expert-led webinars, and on-demand instrument and measurement demonstrations in our online resource library. Get instant, full-length access to all resources related to this podcast using the form below.
This resource collection includes: